Axcelis Announces Timing and Availability of Second Quarter 2026 Results and Conference Call
BEVERLY, Mass., July 22, 2026 /PRNewswire/ — Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor... Read more.
Salt Security Launches in Australia with Local Infrastructure and Dedicated Sales Team
Salt Security announces its official entry into the Australian market, bringing local AWS-hosted infrastructure and a dedicated in-country team to meet growing enterprise... Read more.
Crystalys Therapeutics Announces $130 Million Series B Financing to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout
Financing led by Frazier Life Sciences with participation from Wellington Management, HBM Healthcare Investments, Soleus Capital, Cormorant Asset Management, Trails... Read more.
Two BRAINBox Solutions’ SAB Members to Participate in Key Panel at ADLM Meeting on Biomarker Use in Mild Traumatic Brain Injury Diagnosis/Prognosis
RICHMOND, Va., July 22, 2026 /PRNewswire/ — ‐ BRAINBox Solutions today announced that two of its Scientific Advisory Board (SAB) members will participate... Read more.
Pentera and Recorded Future Partner to Deliver Threat-Led Exposure Validation
New integration turns threat intelligence into validated, prioritized exposure reduction BOSTON, July 22, 2026 /PRNewswire/ — Pentera, the leader in AI-powered... Read more.
Granite Named Preferred Communications Infrastructure Provider for Simon®
Granite Grid to Deliver Next-Generation Connectivity Across Simon’s Premier Retail Destinations QUINCY, Mass., July 22, 2026 /PRNewswire/ — Granite Telecommunications,... Read more.
ITRC: Malicious Insiders Surge as H1 2026 Data Compromises Set Pace for Record Year
More than 471 million victim notices issued in the first six months of the year eclipse the entire 12-month total for 2025 SAN DIEGO, July 22, 2026 /PRNewswire/... Read more.
Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway
Government acceptance initiates formal regulatory review of Entolimod under Ukraine’s Regulatory Equivalency pathway, with a potential review expected in as... Read more.
TuHURA Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference
TAMPA, Fla., July 22, 2026 /PRNewswire/ — TuHURA Biosciences, Inc. (NASDAQ:HURA) (“TuHURA” or the “Company”), a Phase 3 immuno-oncology... Read more.
Exposure to Weed Killer During Pregnancy May Increase Risk of Preterm Birth
NEW YORK, July 22, 2026 /PRNewswire/ — Exposure to a widely used herbicide during the middle months of pregnancy may increase the chance of giving birth too... Read more.